Identification of a rectal subregion highly predictive of rectal bleeding in prostate cancer IMRT

Radiother Oncol. 2016 Jun;119(3):388-97. doi: 10.1016/j.radonc.2016.04.023. Epub 2016 May 9.

Abstract

Background and purpose: To identify rectal subregions at risks (SRR) highly predictive of 3-year rectal bleeding (RB) in prostate cancer IMRT.

Materials and methods: Overall, 173 prostate cancer patients treated with IMRT/IGRT were prospectively analyzed, divided into "training" (n=118) and "validation" cohorts (n=53). Dose-volume histograms (DVHs) were calculated in three types of rectal subregions: "geometric", intuitively defined (hemi-rectum,…); "personalized", obtained by non-rigid registration followed by voxel-wise statistical analysis (SRRp); "generic", mapped from SRRps, located within 8×8 rectal subsections (SRRg). DVHs from patients with and without RB were compared and used for toxicity prediction.

Results: Training cohort SRRps were primarily within the inferior anterior hemi-rectum and upper anal canal, with 3.8Gy mean dose increase for Grade⩾1 RB patients. The SRRg, representing 15% of the absolute rectal volume, was located in 10 inferior-anterior rectal subsections. V18-V70 for SRRps and V58-V65 for SRRg were significantly higher for RB patients than non-RB. Maximum areas under the curve (AUCs) for SRRp and SRRg RB prediction were 71% and 64%, respectively. The validation cohort confirmed the predictive value of SRRg for Grade⩾1 RB. The total cohort confirmed the predictive value of SRRg for Grade⩾2 RB. Geometrical subregions were not RB predictors.

Conclusion: The inferior-anterior hemi anorectum was highly predictive of RB.

Keywords: Inverse planning; Prediction model; Prostate cancer radiotherapy; Rectal bleeding; Specific patient; Toxicity.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Gastrointestinal Hemorrhage / etiology*
  • Humans
  • Male
  • Middle Aged
  • Organs at Risk
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / radiotherapy*
  • Radiotherapy, Intensity-Modulated / adverse effects*
  • Rectal Diseases / etiology*